0552130 - ÚOCHB 2022 RIV kor P - Patent Document
Jansa, Petr - Šimon, Petr - Lansdon, E. - Hu, Y. E. - Baszczyňski, Ondřej - Dejmek, Milan - Mackman, R.
HIV를 치료하는데 사용되는 퀴나졸린 유도체.
[Quinazoline derivatives used to treat HIV.]
2021. Owner: Gilead Sciences, Inc. - Ústav organické chemie a biochemie AV ČR, v. v. i. Date of the patent acceptance: 11.08.2021. Patent Number: KR102288855
Institutional support: RVO:61388963
Keywords : quinazoline * reverse transcriptase * antiviral * NNRTI
OECD category: Organic chemistry
https://worldwide.espacenet.com/patent/search/family/055305044/publication/KR102288855B1?q=KR2288855
Permanent Link: http://hdl.handle.net/11104/0327279
Jansa, Petr - Šimon, Petr - Lansdon, E. - Hu, Y. E. - Baszczyňski, Ondřej - Dejmek, Milan - Mackman, R.
HIV를 치료하는데 사용되는 퀴나졸린 유도체.
[Quinazoline derivatives used to treat HIV.]
2021. Owner: Gilead Sciences, Inc. - Ústav organické chemie a biochemie AV ČR, v. v. i. Date of the patent acceptance: 11.08.2021. Patent Number: KR102288855
Institutional support: RVO:61388963
Keywords : quinazoline * reverse transcriptase * antiviral * NNRTI
OECD category: Organic chemistry
https://worldwide.espacenet.com/patent/search/family/055305044/publication/KR102288855B1?q=KR2288855
Permanent Link: http://hdl.handle.net/11104/0327279